BRIEF published on 01/20/2025 at 08:35, 1 year 7 months ago TRILOGIQ: Résultats semestriels en croissance au 30 septembre 2024 Chiffre D'affaires Résultats Financiers Croissance Standardisation TRILOGIQ
PRESS RELEASE published on 01/20/2025 at 08:30, 1 year 7 months ago TRILOGIQ - Comptes consolidés semestriels au 30 septembre 2024 Croissance de 8,3% du chiffre d'affaires à 12,1 M€ pour TRILOGIQ au 30/09/2024. Bonnes performances en Europe, Amériques et Afrique du Sud. Marge brute de 64,1%. EBITDA consolidé triplé à 1,194 M€ Chiffre D'affaires Croissance EBITDA Marge Brute TRILOGIQ
BRIEF published on 07/02/2024 at 08:35, 2 years 2 months ago TRILOGIQ Shows Solid Growth and Improved Margins in 2024 Financial Results Treasury Growth Margin TRILOGIQ
BRIEF published on 07/02/2024 at 08:35, 2 years 2 months ago TRILOGIQ Affiche une Croissance Solide et une Amélioration des Marges en 2024 Résultats Financiers Croissance Trésorerie Marge TRILOGIQ
PRESS RELEASE published on 07/02/2024 at 08:30, 2 years 2 months ago TRILOGIQ - Comptes consolidés annuels au 31 mars 2024 TRILOGIQ : Croissance du chiffre d'affaires et redressement des marges lors de l'exercice 2023-2024. Analyse des principaux indicateurs financiers et perspectives pour 2024-2025 Chiffre D'affaires Croissance Perspectives Marges TRILOGIQ
BRIEF published on 05/13/2024 at 08:05, 2 years 3 months ago TRILOGIQ annonce une hausse de 15% de son carnet de commandes pour 2023-2024 Croissance EBITDA Europe Carnet De Commandes TRILOGIQ
BRIEF published on 05/13/2024 at 08:05, 2 years 3 months ago TRILOGIQ announces a 15% increase in its order book for 2023-2024 EBITDA Europe Growth Backlog TRILOGIQ
PRESS RELEASE published on 05/13/2024 at 08:00, 2 years 3 months ago TRILOGIQ - Carnet de commandes consolidé annuel au 31 mars 2024 Le carnet de commandes consolidé annuel du groupe TRILOGIQ affiche une croissance de 15% à 25,3 M€ pour l'exercice 2023-2024, marquée par des hausses en Europe et en Amériques Croissance EBITDA Europe Carnet De Commandes TRILOGIQ
Published on 09/12/2026 at 02:35, 14 hours 58 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 18 hours 33 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 19 hours 28 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 20 hours 8 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 10 hours 2 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 19 hours 18 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 19 hours 22 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 21 hours 48 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 23 hours 17 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 22 hours ago Availability of the 2026 Interim Financial Report
